Cardiol Therapeutics
CRDL

Cardiol Therapeutics (CRDL) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
Canaccord GenuityMaintainedBuy$10.00 from $8.00Aug 17, 2026
HC Wainwright & Co.MaintainedBuy$9.00Jul 14, 2026
Canaccord GenuityMaintainedBuy$8.00Apr 6, 2026
HC Wainwright & Co.MaintainedBuy$9.00Feb 10, 2026
HC Wainwright & Co.MaintainedBuy$9.00Dec 1, 2025
HC Wainwright & Co.Initiated CoverageBuy$9.00Jun 2, 2025
HC Wainwright & Co.MaintainedBuy$9.00Apr 16, 2025
HC Wainwright & Co.MaintainedBuy$9.00Apr 7, 2025
HC Wainwright & Co.MaintainedBuy$9.00Feb 24, 2025
HC Wainwright & Co.MaintainedBuy$9.00Dec 18, 2024
HC Wainwright & Co.MaintainedBuy$9.00Nov 20, 2024
HC Wainwright & Co.MaintainedBuy$9.00Oct 24, 2024
Roth MKMInitiated CoverageBuy$10.00Jun 26, 2024
HC Wainwright & Co.MaintainedBuy$9.00Jun 14, 2024
HC Wainwright & Co.MaintainedBuy$9.00Jun 7, 2024
Canaccord GenuityMaintainedBuy$8.00 from $6.00May 23, 2024
HC Wainwright & Co.MaintainedBuy$9.00May 14, 2024
HC Wainwright & Co.Initiated CoverageBuy$9.00Apr 22, 2024
Cantor FitzgeraldMaintainedOverweight$3.00Aug 14, 2023
Canaccord GenuityMaintainedBuy$6.00 from $5.00May 19, 2023

Frequently asked questions

  • What is the latest analyst rating on CRDL?

    On Aug 17, 2026, Canaccord Genuity maintained Cardiol Therapeutics at Buy with a price target of $10.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.